SC 13G: Cabaletta Bio, Inc.
Ticker: CABA · Form: SC 13G · Filed: Aug 22, 2024 · CIK: 1759138
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Cabaletta Bio, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,264 words · 5 min read · ~4 pages · Grade level 10 · Accepted 2024-08-22 18:10:26
Key Financial Figures
- $0.00001 — INC. (Name of Issuer) Common Stock, $0.00001 par value per share (Title of Class
Filing Documents
- d882108dsc13g.htm (SC 13G) — 49KB
- 0001193125-24-205483.txt ( ) — 50KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct. Dated: August 22, 2024 Bain Capital Life Sciences Opportunities III, LP By: Bain Capital Life Sciences Opportunities III GP, LLC, its general partner By: Bain Capital Life Sciences Fund III, L.P., its sole member By: Bain Capital Life Sciences III General Partner, LLC, its general partner By: Bain Capital Life Sciences Investors, LLC, its manager By: /s/ Andrew Hack Name: Andrew Hack Title: Partner